Real-World Outcomes of Abemaciclib Dose-Escalation Strategy in High-Risk Early Breast Cancer

Clinical Breast Cancer 2026

View at publisher

Authors: Noor Lad, Sarah Blocker, Taylor Monson, Dennis W. Grauer, Anne P. O’Dea

DOI: 10.1016/j.clbc.2026.03.008

Cited by: 1

References: 14

Fields of Study & Subjects

Advanced Breast Cancer Therapies Cancer-related Molecular Pathways HER2/EGFR in Cancer Research

References 14